Directory
>
Sadik Kassim
Sadik Kassim
CSO/CTO (Genomic Medicines) | RA Capital Management
Boston, Massachusetts, United States
Sadik Kassim
Summary
Sadik Kassim is a seasoned executive in the biotechnology sector, currently serving as Chief Scientific Officer and Chief Technology Officer at Danaher Genomic Medicines. With a PhD in Microbiology and Immunology from Louisiana State University, he possesses extensive expertise in AAV-based gene therapy, immunotherapy, and oncology. His career spans leadership roles in both startups and Fortune 500 companies, showcasing his ability to build and guide high-performing teams. Sadik has a proven track record in developing R&D strategies and driving innovation in gene and cell therapies. He has played a pivotal role in advancing clinical trials and regulatory submissions, contributing to significant breakthroughs in cancer treatments. His unique blend of scientific acumen and leadership experience positions him as a key influencer in the biotech landscape.
Sadik Kassim
Work Experience
CSO/CTO (Genomic Medicines) at
Danaher Corporation
December 2021 - Present
Advisor at
RA Capital Management
December 2021 - Present
Chief Technology Officer at
Vor Biopharma Inc.
October 2019 - December 2021
Executive Director, Process Design at
Kite Pharma
January 2019 - September 2019
Chief Scientific Officer at
Mustang Bio
March 2018 - January 2019
Vice President, Process and Analytical Development at
Mustang Bio
February 2017 - February 2018
Cell and Gene Therapies Unit (Head of Early Analytical Development) at
Novartis
March 2014 - February 2017
The Surgery Branch (Research Biologist) at
The National Institutes of Health
March 2012 - March 2014
Discovery Immunology (Postdoctoral Research Fellow) at
Johnson & Johnson
January 2011 - February 2012
Gene Therapy Program (Postdoctoral Research Fellow) at
University of Pennsylvania
August 2007 - January 2011
Sadik Kassim
Education
Louisiana State University, Doctor Of Philosophy (Phd)
January 2002 - January 2007
Tulane University, Bachelor Of Science (Bs)
January 1998 - January 2002
Frequently Asked Questions about Sadik Kassim
What is Sadik Kassim email address?
Sadik Kassim's primary email address is ************@danaher.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Sadik Kassim work for?
Sadik Kassim is a CSO/CTO (Genomic Medicines) at RA Capital Management, a company specializing in Security brokers & dealers.
Where Sadik Kassim graduated from?
Sadik Kassim holds a degree in Microbiology And Immunology from Louisiana State University.
How can I directly contact Sadik Kassim?
To contact Sadik Kassim directly, you can use the email address ************@danaher.com. Complete contact information is available upon registration with Muraena.
Who is Sadik Kassim?
Sadik Kassim is a seasoned executive in the biotechnology sector, currently serving as Chief Scientific Officer and Chief Technology Officer at Danaher Genomic Medicines. With a PhD in Microbiology and Immunology from Louisiana State University, he possesses extensive expertise in AAV-based gene therapy, immunotherapy, and oncology. His career spans leadership roles in both startups and Fortune 500 companies, showcasing his ability to build and guide high-performing teams. Sadik has a proven track record in developing R&D strategies and driving innovation in gene and cell therapies. He has played a pivotal role in advancing clinical trials and regulatory submissions, contributing to significant breakthroughs in cancer treatments. His unique blend of scientific acumen and leadership experience positions him as a key influencer in the biotech landscape.
Sadik`s contact details
************@danaher.com
************@novartis.com
Colleagues
Managing Director
Managing Director & Portfolio Manager
Chief Compliance Officer
Managing Partner, Planetary Health
Chief Financial Officer